Q2 2023 Flora Growth Corp Earnings Call
We are confident in the trajectory we've set, and we are committed to delivering value to our shareholders. I will now hand the call back to the operator for the question and answer session.
Thank you for standing by. This is the conference operator. Welcome to the FLORA GrowthCorp Q2 2023 results and
As a reminder, all participants are in listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. To join the question queue, you may press star, then 1 on your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star, then 0. I would now like to turn the conference over to Dani Vaman, Chief Financial Officer. Please go ahead. Thank you, operator, and good morning, everyone.
Once again, if you have a question, please press star then one. As there are no questioners in the queue, this concludes the question and answer session. I would like to turn the conference back over to Clifford Stark for any closing remarks. Thank you operator and thank you all for joining the call today. We look forward to continuing updating you on the progress in the quarters ahead. Thank you and have a great day.
On behalf of the FLORA team, welcome to our Q2 2023 and Corporate Update Conference Call.
Before we begin, I wish to inform listeners that certain statements to be made today by the management team may contain forward-looking information. Today's call will include estimates and other forward-looking information and statements concerning future events, revenues, and financial statements.
This concludes today's conference call. You may disconnect your lines. Thank you for participating and have a pleasant day.
results from operations, financial position, market, economic conditions, partnerships, and any other statements that may be constructed as a prediction of future performance.
Musicumping
The information may involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements.
Doctors that could cause or contribute to such differences are described in details in the company's most recent filings available on EDGAR at sec.gov and CDAR at CDAR.com. Any estimates of forward-looking information or statements provided are not intended to be
are accurate only as of the date of this call and the company undertakes no obligation to publicly update any forward-looking information or supply any new information regarding the circumstances after the date of this call.
On the call today, we have Clifford Stark, CEO , and myself, Danny Bayman, CFO . Following the presentation, Clifford and I will be available for the question and answer period. The Q3 2022 and 2023 results press release and accompanying 10Q have been filed on EDGAR and CEDAR.
Also note that all amounts mentioned on this call are United States dollars unless otherwise stated. I'll now turn the call over to Clifford. Thank you, Danny, and good morning, everyone on the line. Welcome to the FloraGrow Q2 2023 results call.
I'll open by saying that when we were appointed in late June , Ford needed stability and direction in this challenging environment.
The company's Colombian operations were not performing and corporate overhead was larger than what gross margins could sustain. We knew we had to make changes and make them quickly. We decided to divest for its Colombian operations and implemented $6.1 million of cost savings, which includes a significant reduction in corporate overhead. While we believe favorable regulatory outcomes around adult use cannabis are likely in both the United States and Europe and would deliver significant upside in time, we do not intend to structure Flora as a company dependent on legalization, as we will form additional similar partnerships with entertainers and celebrities in the near future. Vessel is a leading brand of consumer technology, including vape pens, batteries, and accessories. The Vessel product base are all premium and have an extremely high loyalty factor. We anticipate saving growth for Vessel in the coming quarters. Fatibo is a German-based distributor of padded brand pharmaceuticals with an outreach to 28 countries. We believe Fatibo's potential to become an important player in therapeutics, marketing new cannabis products to the European market to start. The downturn in the global financial markets, particularly within the cannabis space, continues to be a challenge facing the industry. We remain optimistic about the sector's long-term prospects. Now is the time for the industry to consolidate, reduce costs, and build efficient models that can withstand the impact of broader economic weaknesses. Companies who will view the current conditions as a clear indication of evolution will emerge stronger and generate higher than average returns. With that, I'm going to pass along to Danny who will go over the financial results.